Study Title: A Phase Ib/II Study of Anti-PD-1 Antibody Pembrolizumab and Imprime PGG for Patients with Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy
 

• Closed to Accrual at:
  • University of Illinois Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • Rutgers Cancer Institute of New Jersey
• Learn more:
  • clinicaltrials.gov: NCT03003468
  • Big Ten CRC News Release
• Publications and Presentations:
  • Featured Poster: IASLC World Conference on Lung Cancer 2020
  • Poster: IASLC World Conference on Lung Cancer 2020
  • Poster: IASLC World Conference on Lung Cancer 2018

Study Contact: studies@hoosiercancer.org; (317) 921-2050.